Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs-Reference-Cited by-同舟云学术

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs

Published:2020-06-09 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zepeda-Cervantes Jesús,Ramírez-Jarquín Josué Orlando,Vaca Luis

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference252 articles.

1. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells;Barth;Blood,2005

2. Virus-like particles: the new frontier of vaccines for animal viral infections;Crisci;Vet Immunol Immunopathol,2012

3. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes;Bachmann;Eur J Immunol,1996

4. Dendritic cells and the control of immunity;Banchereau;Nature,1998

5. Coordinated events during bacteria-induced DC-maturation;Rescigno;Immunol Today,1999

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactobacillus casei displaying MCP2α and FlaC delivered by PLA microspheres effectively enhances the immune protection of largemouth bass (Micropterus salmoides) against LMBV infection;Fish & Shellfish Immunology;2024-10

2. Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus;International Journal of Molecular Sciences;2024-09-12

3. Virus-like particles in poultry disease: an approach to effective and safe vaccination;Frontiers in Veterinary Science;2024-09-09

4. Influenza A Vaccine Candidates Based on Virus-like Particles Formed by Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465;Vaccines;2024-09-09

5. Molecular Design of Encapsulin Protein Nanoparticles to Display Rotavirus Antigens for Enhancing Immunogenicity;Vaccines;2024-09-06